This activation occurs through the JAK/STAT3 signaling pathway, and mediates phenotypic changes in the treated cells, including enhanced cell proliferation and transformation of the cells to increase production of cytokines, which may promote tumor formation. The gene discussed is STAT3; the disease is neoplasm.